Bridge drug may help parolees beat opioid addiction
NCT ID NCT03616236
First seen Feb 03, 2026 · Last updated May 14, 2026 · Updated 14 times
Summary
This study tests whether giving buprenorphine (a medication for opioid addiction) as a bridge treatment helps people on probation or parole stop using illicit opioids and stay in treatment. About 320 adults in Baltimore will either receive the bridge treatment or be referred to a community program as usual. The goal is to see if starting medication right away improves outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Division of Parole & Probation
Baltimore, Maryland, 21202, United States
Conditions
Explore the condition pages connected to this study.